A socially oriented non-financial development institution and a major organizer of nationwide and international conventions; exhibitions; and business, public, youth, sporting, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of nationwide and international conventions; exhibitions; and business, public, youth, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5,000 people working in Russia and abroad.

The Foundation works alongside various UN departments and other international organizations, and is building multi-format cooperation with 173 economic partners, including industrialists’ and entrepreneurs’ unions, financial, trade, and business associations from 78 countries worldwide, and 188 Russian public organizations, federal and legislative agencies, and federal subjects.

The Roscongress Foundation has Telegram channels in Russian t.me/Roscongress, English – t.me/RoscongressDirect, and Spanish t.me/RoscongressEsp. Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Vasily Ignatiev

Vasily Ignatiev

General Director, R-Pharm
SPIEF 2021
Healthcare as Investment: Public and Private Partnership in the Pharmaceutical Sector
People say that Covid made us rethink our views on the supply chain. What used to work without interruptions and was reliable, it stopped working at times, and there were major failures. We have learned to cope with that somehow, there are certain measures and steps that are planned. In particular, there is a big discussion about how to develop the production of substances within the Pharma 2030 programme, among other things
SPIEF 2019
Innovative development of the pharmaceutical and biotech industry in Russia: keys to success
What does it take to persuade a Russian bank to issue a loan for investing in R&D? <...> They fear it as the devil fears the holy water. If you succeed, you need to include production sites, property rights for real estate, etc. RVC along with some other development institutions offer financing mechanisms, but it is not enough
SPIEF 2018
Life Sciences in 2030: A New Era for Biotechnology
In Russia, many projects are conducted in a format of collective development at the junction of commercial players and academic science in the universities. Here we face the lack of a culture of protecting intellectual property rights of scientific groups. Often times, research teams do not have enough resources and they simply ignore timely protection. A negative factor is a KPI development by the regulator, when the scientific teams are evaluated by citation indexes and publications. They chase it and go out into the public field before it's necessary, and lose the opportunity to patent their designs
SPIEF 2018
Providing Medications to the Russian Population
An auction is not an appropriate means of procurement when there is an original drug and a single producer who is not competing with anyone. We need to enter into more price negotiations based on long-term demand and price vs. volume